Tabcorp Holdings Limited Reported 71% growth in topline after its combination with Tatts Group

Tabcorp Kalkine

Strong FY 18 performance: Tabcorp Holdings Limited’s (ASX: TAH) stock surged 7.556% on August 08, 2018 (before market close) after the company for FY 18 reported 71% growth in the revenue to $3,828.7m. The company has posted 2018 NPAT of $28.7m, up from $20.8m loss in pcp. Moreover, TAH has completed combination with Tatts Group and the integration is on track. As a result, the company delivered $8m in FY 18, and the decisions taken underpin $50m in FY19 and the target is at least $130m in FY21.

The company during 2018 had exited loss-making businesses as Sun Bets exit was announced in July 2018 and Luxbet closure in December 2017. TAH in 2018 refinanced $1.8bn bridge loan into long-dated maturities in US market and declared full year dividend of 21.0 cps, including final dividend of 10.0 cps. Additionally, TAH had positive 2H18 performance, driven by Wagering & Media and Lotteries & Keno, which had accelerated digitalisation across the company, launched new products and renewed licences. Therefore, TAH stock has risen 5.63% in three months as on August 07, 2018.

image !! 11.png

FY 18 Financial Performance (Source: Company Reports)

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

Sponsored ad by Kalkine

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here